13 November 2015
Optimising Gene Medicine Delivery for Duchenne Muscular Dystrophy
Organised by:
SCI's Biotechnology Group in partnership with the University of Westminster
University of Westminster
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
Delivery of therapeutic gene medicines is a fundamental problem that hinders the developmental pipeline of many translational programmes. Viral vectors and antisense oligonucleotides are both at the forefront of therapeutic programmes for Duchenne muscular dystrophy. The presentation will focus on (i) approaches to delivery full length dystrophin; a large gene cargo and (ii) optimising the delivery of antisense oligonucleotide to restore dystophin expression.Programme
Accessibility Grants
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Venue and Contact
University of Westminster
University of WestminsterSchool of Life Sciences
115 New Cavendish Street
London W1W 6UW
Please click here for a location map.
SCI Comms Team
Tel: +44 (0) 20 7598 1594
Email: communications@soci.org
Fees
This is a free event, no need to book. Please check this page for any updates or changes before attending the event.
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
CPD Info
SCI Members attending this meeting are able to claim CPD points.
Additional Info
Speaker
Dr Keith Foster
Associate Professor in Translational Medicine, School of Biological Sciences, University of Reading